Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4372

1.

Carbocisteine Improves Histone Deacetylase 2 Deacetylation Activity via Regulating Sumoylation of Histone Deacetylase 2 in Human Tracheobronchial Epithelial Cells.

Song Y, Chi DY, Yu P, Lu JJ, Xu JR, Tan PP, Wang B, Cui YY, Chen HZ.

Front Pharmacol. 2019 Feb 27;10:166. doi: 10.3389/fphar.2019.00166. eCollection 2019.

2.

The Use of Assessment of Chronic Illness Care Technology to Evaluate the Institutional Capacity for HIV/AIDS Management.

da Silva AWM, Meiners MMMA, Noronha EF, de Toledo MI.

Front Pharmacol. 2019 Feb 27;10:165. doi: 10.3389/fphar.2019.00165. eCollection 2019.

3.

Evolution to a Competency-Based Training Curriculum for Pharmaceutical Medicine Physicians in Switzerland.

Schnetzler G, Bremgartner MF, Grossmann Straessle R, Spirk D, Tay F, Troxler Saxer R, Traber M.

Front Pharmacol. 2019 Feb 27;10:164. doi: 10.3389/fphar.2019.00164. eCollection 2019.

4.

Icariin Protects Bone Marrow Mesenchymal Stem Cells Against Iron Overload Induced Dysfunction Through Mitochondrial Fusion and Fission, PI3K/AKT/mTOR and MAPK Pathways.

Yao X, Jing X, Guo J, Sun K, Deng Y, Zhang Y, Guo F, Ye Y.

Front Pharmacol. 2019 Feb 28;10:163. doi: 10.3389/fphar.2019.00163. eCollection 2019.

5.

The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review.

Yun SM, Kim SH, Kim EH.

Front Pharmacol. 2019 Feb 27;10:162. doi: 10.3389/fphar.2019.00162. eCollection 2019. Review.

6.

Modified Si-Jun-Zi-Tang Attenuates Airway Inflammation in a Murine Model of Chronic Asthma by Inhibiting Teff Cells via the mTORC1 Pathway.

Jin H, Cai C, Li B, Jin W, Xia J, Wang L, Ma S.

Front Pharmacol. 2019 Feb 27;10:161. doi: 10.3389/fphar.2019.00161. eCollection 2019.

7.

Efficient Treatment of Sporothrix globosa Infection Using the Antibody Elicited by Recombinant Phage Nanofibers.

Chen F, Jiang R, Dong S, Yan B.

Front Pharmacol. 2019 Feb 27;10:160. doi: 10.3389/fphar.2019.00160. eCollection 2019.

8.

Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA ("Ecstasy") in Rats and Preserves Affinity for the Serotonin Transporter (SERT).

Sáez-Briones P, Castro-Castillo V, Díaz-Véliz G, Valladares L, Barra R, Hernández A, Cassels BK.

Front Pharmacol. 2019 Feb 28;10:157. doi: 10.3389/fphar.2019.00157. eCollection 2019.

9.

Protective Effects of Protegrin in Dextran Sodium Sulfate-Induced Murine Colitis.

Huynh E, Penney J, Caswell J, Li J.

Front Pharmacol. 2019 Feb 28;10:156. doi: 10.3389/fphar.2019.00156. eCollection 2019.

10.

Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction.

Loi H, Boal F, Tronchere H, Cinato M, Kramar S, Oleshchuk O, Korda M, Kunduzova O.

Front Pharmacol. 2019 Feb 27;10:154. doi: 10.3389/fphar.2019.00154. eCollection 2019.

11.

Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis.

Ghareghani M, Scavo L, Jand Y, Farhadi N, Sadeghi H, Ghanbari A, Mondello S, Arnoult D, Gharaghani S, Zibara K.

Front Pharmacol. 2019 Feb 28;10:147. doi: 10.3389/fphar.2019.00147. eCollection 2019.

12.

Re-establishing Apoptosis Competence in Bone Associated Cancers via Communicative Reprogramming Induced Through Notch Signaling Inhibition.

Colombo M, Platonova N, Giannandrea D, Palano MT, Basile A, Chiaramonte R.

Front Pharmacol. 2019 Feb 27;10:145. doi: 10.3389/fphar.2019.00145. eCollection 2019. Review.

13.

The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Li Y, He M, Zhou Y, Yang C, Wei S, Bian X, Christopher O, Xie L.

Front Pharmacol. 2019 Feb 28;10:139. doi: 10.3389/fphar.2019.00139. eCollection 2019.

14.

Attitudes, Practices, and Barriers of Malaysian Community Pharmacists Toward Provision of Weight Management Services.

Verma RK, Paraidathathu T, Taha NA, Chong WW.

Front Pharmacol. 2019 Feb 22;10:138. doi: 10.3389/fphar.2019.00138. eCollection 2019.

15.

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers.

Martínez-Riera R, Pérez-Mañá C, Papaseit E, Fonseca F, de la Torre R, Pizarro N, Torrens M, Farré M.

Front Pharmacol. 2019 Feb 27;10:131. doi: 10.3389/fphar.2019.00131. eCollection 2019.

16.

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine.

Pranke I, Golec A, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

Front Pharmacol. 2019 Feb 27;10:121. doi: 10.3389/fphar.2019.00121. eCollection 2019. Review.

17.

Lipid Nanoparticles-Encapsulated YF4: A Potential Therapeutic Oral Peptide Delivery System for Hypertension Treatment.

Zhao S, Li J, Zhou Y, Huang L, Li Y, Xu J, Fu C, Guo X, Yang J.

Front Pharmacol. 2019 Feb 19;10:102. doi: 10.3389/fphar.2019.00102. eCollection 2019.

18.

Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor.

Lu TL, Chang WT, Chan CH, Wu SN.

Front Pharmacol. 2019 Feb 18;10:76. doi: 10.3389/fphar.2019.00076. eCollection 2019.

19.

Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov.

Chen L, Su Y, Quan L, Zhang Y, Du L.

Front Pharmacol. 2019 Feb 26;9:1574. doi: 10.3389/fphar.2018.01574. eCollection 2018.

20.

Erratum: Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma.

Frontiers Pharmacology Editorial Office.

Front Pharmacol. 2019 Feb 26;10:213. doi: 10.3389/fphar.2019.00213. eCollection 2019.

Supplemental Content

Loading ...
Support Center